04.12.2020

(DVCA) Notification on Corporate Action "Cash Dividend" - Takeda Pharmaceutical Company Ltd ORD SHS ADR (depositary receipts ISIN US8740602052)

Corporate Action Information
Corporate Action Reference 526417
Corporate Action Type Code DVCA
Corporate Action Type Cash Dividend
Mandatory indicator MAND Mandatory
Value date 11 dec 2020

Security Details
Corporate Action Security Reference Issuer Security Name Category NSD Code ISIN Underlying Security Issuer Underlying Security Type Ratio ( Number of DR/ Number of Underlying Securities)
526417D250 BNY Mellon Takeda Pharmaceutical Company Ltd ORD SHS ADR American depository receipt US8740602052 US8740602052 Takeda Pharmaceutical Company Limited shares ordinary 2 : 1

Corporate Action Details
Record Date 30 sep 2020

National Settlement Depository (NSD) notifies that the additional information regarding Cash Dividend has been received from International Settlement and Clearing Organization.
Value date has been announced.
Detailed information regarding this corporate action event will be provided to holders who have balances of these securities on their safekeeping accounts with NSD.

If you have any questions related to this communication, please contact your account managers at NSD by telephone: +7 495 956-27-90 or +7 495 956-27-91.

Print page